The CRUK Bridge to Academic Leadership (BAL) programme supports early career researchers transitioning to independence by equipping them with leadership, grant-writing, and strategic skills. Overall: The BAL programme offers practical […]
Summary – Epigenetic Checkpoint BlockadeCheckpoint inhibitors targeting immune checkpoints have revolutionised cancer treatment, but a new frontier lies in epigenetic checkpoints. These act at the chromatin level to silence retroelements—ancient […]
Researchers at Kyoto University’s iCeMS have developed a protein-based tool called Crunch (Connector for Removal of Unwanted Cell Habitat) that reprogrammes the immune system’s natural clearance process. Normally, phagocytes remove dead cells through phagocytosis, […]
UCLA researchers have developed a new “off-the-shelf” cell therapy that shows promise for treating renal cell carcinoma (RCC), the most common type of kidney cancer. The therapy uses stem cell–derived, […]
A new DNA test could one day help doctors find which chemotherapy drugs are most likely to work for their patients, according to research we helped fund. It works by […]
A landmark study headed by researchers at Yale School of Medicine and at Fred Hutchinson Cancer Center has revealed that autoantibodies (AAbs)—immune proteins traditionally associated with autoimmune disease—may profoundly influence […]